National Research (NRCIA) vs. Its Competitors Head-To-Head Survey

National Research (NASDAQ: NRCIA) is one of 97 publicly-traded companies in the “Business Support Services” industry, but how does it weigh in compared to its peers? We will compare National Research to similar companies based on the strength of its institutional ownership, profitability, risk, analyst recommendations, dividends, valuation and earnings.


National Research pays an annual dividend of $0.40 per share and has a dividend yield of 1.0%. National Research pays out 45.5% of its earnings in the form of a dividend. As a group, “Business Support Services” companies pay a dividend yield of 1.0% and pay out 25.4% of their earnings in the form of a dividend.

Institutional & Insider Ownership

25.1% of National Research shares are held by institutional investors. Comparatively, 63.5% of shares of all “Business Support Services” companies are held by institutional investors. 37.5% of National Research shares are held by insiders. Comparatively, 12.3% of shares of all “Business Support Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.


This table compares National Research and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
National Research 19.09% 30.84% 21.29%
National Research Competitors -18.14% -18.66% 1.48%

Earnings & Valuation

This table compares National Research and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
National Research $109.38 million $20.51 million 43.35
National Research Competitors $1.27 billion $76.68 million 1,588.21

National Research’s peers have higher revenue and earnings than National Research. National Research is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and price targets for National Research and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research 0 1 0 0 2.00
National Research Competitors 634 1930 2709 67 2.41

National Research presently has a consensus price target of $44.00, suggesting a potential upside of 15.33%. As a group, “Business Support Services” companies have a potential downside of 1.92%. Given National Research’s higher probable upside, equities analysts clearly believe National Research is more favorable than its peers.

Risk and Volatility

National Research has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, National Research’s peers have a beta of 1.12, meaning that their average share price is 12% more volatile than the S&P 500.


National Research peers beat National Research on 8 of the 15 factors compared.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement. NRC Health partners with clients across the range of healthcare services. The Company’s clients range from integrated health systems and post-acute providers, such as home health, long-term care and hospice, to payer organizations. NRC Health’s portfolio of solutions is designed to help healthcare companies.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with's FREE daily email newsletter.

Leave a Reply